What is CBD?
CBD is short for Cannabidiol, which is a chemical compound found naturally in cannabis.
Cannabidiol (CBD) is a phytocannabinoid discovered in 1940. It is one of some 113 identified cannabinoids in cannabis plants and accounts for up to 40% of the plant’s extract. In 2018, clinical research on cannabidiol included preliminary studies of anxiety, cognition, movement disorders, and pain.
Cannabidiol can be taken into the body in multiple ways, including by inhalation of cannabis smoke or vapor, as an aerosol spray into the cheek, and by mouth. It may be supplied as CBD oil containing only CBD as the active ingredient (no included tetrahydrocannabinol [THC] or terpenes), a full-plant CBD-dominant hemp extract oil, capsules, dried cannabis, or as a prescription liquid solution. CBD does not have the same psychoactivity as THC, and may affect the actions of THC. As of 2018, the mechanism of action for its biological effects has not been determined.
Unlike other compounds found in cannabis, especially tetrahydrocannabinol (THC), CBD doesn’t induce psychoactive effects associated with cannabis use rather it work against THC to nullify the induced psychoactive effects.
CBD has been at the centre of one of the most exciting and underreported developments in modern science.
Strengthen the Immune System
We all have an Endocannabinoid system (ECS). The ECS is a group of endogenous cannabinoid receptors located in the brain and throughout the central and peripheral nervous systems. CBD specifically interacts with CB1 and CB2 receptors that send signals to wake up and strengthen our immune system naturally. This is because our ECS is intricately linked to our nervous system and immune system, as well as our brain and digestive system.
There has been little high-quality research into the use of cannabidiol for epilepsy. The limited available evidence primarily focuses on refractory epilepsy in children. While the results of using medical-grade cannabidiol in combination with conventional medication shows some promise, they did not lead to seizures being eliminated, and were associated with some minor adverse effects.
Preliminary research on other possible therapeutic uses for cannabidiol include several neurological disorders, but the findings have not been confirmed by sufficient high-quality clinical research to establish such uses in clinical practice.
In the United States, the cannabidiol drug Epidiolex was approved by the Food and Drug Administration in 2018 for treatment of two epilepsy disorders. The side effects of long-term use of the drug include somnolence, decreased appetite, diarrhea, fatigue, malaise, weakness, and sleeping problems. As of April 2019, CBD extracted from marijuana remains a Schedule I drug classification, and is not approved as a prescription drug, dietary supplement, or allowed for interstate commerce in the United States.
Post time: Jun-17-2019